
What topic would you like discussed? Text us!
The headlines makes it sound simple: omalizumab (Xolair) performs as well as or better than multi-food oral immunotherapy for food allergy. But once you look under the hood, the story gets a lot more nuanced and a lot more real. Fresh from the AAAAI 2026 conference, I walk you through what the new data actually show, why the study design isn't ideal, and what parents should ask their allergist before choosing a path, whether that be with Xolair, OIT, SLIT, or avoidance.
Link to the articles I mention:
Food Allergy Peds Hub: https://foodallergypedshub.hoytallergy.com/newsletters/the-food-allergy-friday-newsletter/posts/is-xolair-superior-to-oit
Doximity: https://opmed.doximity.com/articles/aaaai-2026-good-science-great-connections
If this helps you think more clearly about your child's food allergy treatment, subscribe, share the episode with a friend, and leave a review so more families can find it.
Resources
📖 Navigating Food Allergies: A Parent’s Guide to Care, Coverage, and Confidence by Dr. Alice Hoyt - preorder from Amazon and more
For Parents ➡️ Office Hours for Parents
For Providers ➡️ Food Allergy Pediatric Hub
For Schools ➡️ Code Ana
For Potential Patients ➡️ Hoyt Institute of Food Allergy
🔎 Find an Allergist
AAAAI Allergist Finder
ACAAI Allergist Finder
OIT Allergist Finder
This podcast is the official podcast of the Hoyt Institute of Food Allergy. Information on, within, and associated with this site and Food Allergy and Your Kiddo is for educational purposes only and is not medical advice.
Mais episódios de "Food Allergy and Your Kiddo"



Não percas um episódio de “Food Allergy and Your Kiddo” e subscrevê-lo na aplicação GetPodcast.








